Get Your Personalized Supplement StackSupplement Stack Quiz

European Elder Berry

Q: Is elderberry effective for preventing colds and flu?

Evidence suggests elderberry may reduce incidence and severity but is more effective when used at symptom onset.

Q: Can elderberry overstimulate the immune system?

Current evidence shows no risk of immune overstimulation or cytokine storm with elderberry supplementation.

Q: How soon will I see results?

Symptom improvement is typically observed within 2–4 days of starting supplementation.

Q: Are there any risks with long-term use?

Long-term safety data are limited; short-term use during illness is considered safe.

Q: Is elderberry safe for children?

Some studies include children, but dosing and safety should be guided by healthcare professionals.

Also known as: Sambucus nigra L., European Elderberry, Black Elderberry, Sambucus nigra

Overview

European Elderberry (Sambucus nigra) is a flowering plant whose berries and flowers have been traditionally used for medicinal purposes, particularly for respiratory illnesses. The supplement is primarily derived from the berries and sometimes flowers of the plant. It is widely used for its purported antiviral, antioxidant, and anti-inflammatory properties. Research on elderberry has matured to include several randomized controlled trials (RCTs) and systematic reviews, particularly focusing on its effects on upper respiratory tract infections such as the common cold and influenza. The quality of evidence is moderate, with some well-conducted meta-analyses but still limited by relatively small sample sizes and heterogeneity in study designs. Elderberry contains bioactive compounds such as flavonoids (e.g., anthocyanins) that exhibit antiviral activity by inhibiting viral replication and attachment. It is available in various forms, including extracts, syrups, and capsules.

Benefits

Elderberry supplementation significantly reduces the duration and severity of upper respiratory symptoms, including those caused by influenza and the common cold. A meta-analysis including 180 participants found a large mean effect size for symptom reduction (p < 0.05). It may serve as a safer alternative to antibiotics and prescription antiviral drugs for routine viral respiratory infections, potentially reducing antibiotic misuse. Elderberry exhibits antioxidant and anti-inflammatory effects, which may contribute to symptom relief and immune support. Benefits have been observed in generally healthy adults experiencing viral respiratory infections; data on other populations (e.g., children, elderly, immunocompromised) are less robust. The meta-analysis reported a substantial reduction in symptom severity and duration, indicating clinically meaningful benefits. Symptom improvement typically occurs within a few days of supplementation during acute viral illness episodes.

How it works

Elderberry contains bioactive compounds such as flavonoids (e.g., anthocyanins) that exhibit antiviral activity by inhibiting viral replication and attachment. It modulates immune response by reducing pro-inflammatory cytokines without overstimulating the immune system, which may prevent cytokine storm-related complications. Viral envelope proteins and host cell receptors involved in viral entry are key molecular targets. Cytokine signaling pathways including interferons, interleukins, and tumor necrosis factor-alpha (TNF-α) are also affected. Anthocyanins and other polyphenols in elderberry are absorbed in the gastrointestinal tract but have variable bioavailability influenced by formulation and individual metabolism.

Side effects

Elderberry is generally safe when consumed in recommended doses, with no evidence of immune overstimulation or serious adverse effects. Mild gastrointestinal discomfort has been reported in some individuals. Allergic reactions are rare but possible. There are no significant reports of severe adverse events in controlled trials. No well-documented drug interactions exist, but caution is advised when combined with immunomodulatory drugs. Avoid raw or unripe elderberries due to potential cyanogenic glycosides toxicity. Limited data are available for pregnant or breastfeeding women; consultation with a healthcare provider is recommended. Overall, elderberry is considered safe for short-term use during acute illness episodes.

Dosage

Clinical studies typically use elderberry extract doses standardized to anthocyanin content, ranging from 300 to 600 mg per day during acute illness. A dosage of 300–600 mg of standardized elderberry extract daily for 3–5 days is recommended during respiratory infection episodes. There is no established maximum safe dose; doses used in clinical trials have been well tolerated. Initiate supplementation at the onset of symptoms for maximal benefit. Standardized elderberry extracts, syrups, or capsules are preferred for consistent dosing. Bioavailability may be enhanced by formulations that protect anthocyanins from degradation. No specific cofactors are required.

FAQs

Is elderberry effective for preventing colds and flu?

Evidence suggests elderberry may reduce incidence and severity but is more effective when used at symptom onset.

Can elderberry overstimulate the immune system?

Current evidence shows no risk of immune overstimulation or cytokine storm with elderberry supplementation.

How soon will I see results?

Symptom improvement is typically observed within 2–4 days of starting supplementation.

Are there any risks with long-term use?

Long-term safety data are limited; short-term use during illness is considered safe.

Is elderberry safe for children?

Some studies include children, but dosing and safety should be guided by healthcare professionals.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/30670267/ – This meta-analysis of randomized controlled trials found that elderberry supplementation significantly reduced the duration and severity of upper respiratory symptoms. The study included 180 participants and reported a large mean effect size for symptom reduction, supporting elderberry as a safe alternative to antibiotics and antivirals.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8026097/ – This systematic review assessed the effectiveness and safety of elderberry for the prevention and treatment of viral respiratory infections. The review included multiple RCTs and observational studies and concluded that elderberry is effective and safe, with no evidence of harmful immune activation.
https://www.tandfonline.com/doi/full/10.1080/09540105.2021.1978941 – This clinical study on elderberry extract showed antiviral activity and symptom relief in influenza patients. The RCT with standardized elderberry extract found that elderberry extract showed antiviral activity and symptom relief in influenza patients.
https://www.annualreviews.org/content/journals/10.1146/annurev-food-072023-034423?TRACK=RSS – This review provides an overview of the health benefits of berries, including elderberry, highlighting their antioxidant and anti-inflammatory properties. It discusses the potential mechanisms of action and the evidence supporting their use in preventing and treating various diseases.
https://examine.com/supplements/elderberry/ – Examine.com provides a summary of the available research on elderberry, focusing on its effects on immune function and viral infections. It highlights the evidence supporting its use for reducing the duration and severity of colds and flu, as well as its safety profile.